Moderna initiates clinical trials of Omicron-centered booster shots

Moderna initiates clinical trials of Omicron-centered booster shots

Published: Just now By Akshay Kedari

Moderna Inc. recently announced to have started giving adult patients its Omicron-specific COVID-19 vaccine booster shots as a part of a clinical trial. The announcement comes just one day after Pfizer and BioNTech start....

India’s Swiggy is now worth USD 10.7 Bn following a USD 700 Mn funding

India’s food delivery behemoth Swiggy has reportedly bagged USD 700 million in a Series K funding that was spearheaded by Invesco, now valuing the seven-year-old startup at USD 10.7 billion. The recent development comes just six month....

Nissan, Renault, and Mitsubishi to soon reveal their EV plans for 2030

Renault S.A., Mitsubishi Motors Corp., and Nissan Motor Co. are reportedly planning to triple their investment to co-develop electric vehicles (EVs). The French Japanese automotive alliance is planning to strengthen their cooperation as est....

McDonald’s Germany partners with location intelligence firm Targomo

McDonald's Germany has reportedly teamed up with Targomo, a location intelligence business, to meticulously plan its expansion requirements. Targomo uses Artificial Intelligence (AI) to analyze geospatial data and unlock the full potent....

No evidence that healthy children, adolescents need boosters shots: WHO

  Israel has already begun to give booster doses to its 12-year-old children. Even the FDA has authorized the third dose of  Pfizer/BioNTech COVID-19 vaccine for children aged between 12 to 15. There is currently no evidence....

Our Contributors

Mateen Dalal
Akshay Kedari